Larvol Delta - Altimmune-Announces-Initiation-of-Phase-2b-IMPACT-Trial-Evaluating-the-Efcacy-and-Safety-of-Pemvidutide-in-NonAlcoholic-Steatohepatitis-NASH

pemvidutide (ALT-801) - Altimmune

https://www.biospace.com/article/releases/altimmune-announces-initiation-of-phase-2b-impact-trial-evaluating-the-efficacy-and-safety-of-pemvidutide-in-non-alcoholic-steatohepatitis-nash-/

Aug 1, 2023

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next